GlassScriptPhysician profile
Abroo Muzaffar
NPI 1679899447
$1,919.42
in general payments reported to CMS, 2019-2025
9 companies · $73.74 in 2025
The $73.74 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $75.84 · 2023: $1,711 · 2024: $59.29 · 2025: $73.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $990 · Food and Beverage: $790 · Education: $63.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $989.89 |
| Food and Beverage | $789.70 |
| Education | $63.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,648.15 | 2022-2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Actelion Pharmaceuticals US, INC. | $63.99 | 2023 | Uptravi, Opsumit |
| Bolton Medical INC | $53.72 | 2025 | Treo Abdominal Stent-Graft System |
| Abiomed | $43.87 | 2024 | Impella |
| Pfizer INC. | $28.61 | 2023 | |
| Merck Sharp & Dohme LLC | $27.62 | 2023 | Verquvo |
| Novartis Pharmaceuticals Corporation | $20.02 | 2025 | |
| Impulse Dynamics (USA) INC. | $18.02 | 2023 | Optimizer |
| Astrazeneca Pharmaceuticals LP | $15.42 | 2024 | Wainua |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abroo Muzaffar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.